Pharming (PHAR) Receivables (2019 - 2026)
Pharming's Receivables came in at $74.83 million for Q3 2026, up 71.6% from $43.61 million a year earlier and up 31.3% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharming's Receivables was $54.7 million, down 0.2% from FY2024.
- Receivables carries a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- Going back by year, Receivables was $54.82 million in FY2024 (+18.8%), $46.16 million in FY2023 (+67.1%), $27.62 million in FY2022 (-7.9%) and $29.98 million in FY2021 (-16.5%).
- The Q3 2026 figure represents the highest quarterly Receivables in data going back to Q4 2019.
- Year-over-year, Receivables has increased for three consecutive quarters, with growth averaging 17.6% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q3 2026 (growth of 71.6%), and the weakest in Q3 2022 (a decline of 99.9%).
- Business Quant data shows PHAR's Receivables at $56.98 million (Q2 2026), $60.03 million (Q1 2026) and $54.7 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Pharming | 898.85 Mn | 429.52 Mn | - | 54.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 74.83 Mn |
| Jun 30, 2026 | 56.98 Mn |
| Mar 31, 2026 | 60.03 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Sep 30, 2025 | 43.61 Mn |
| Jun 30, 2025 | 53.33 Mn |
| Mar 31, 2025 | 47.49 Mn |
| Dec 31, 2024 | 54.82 Mn |
| Sep 30, 2024 | 48.20 Mn |
| Jun 30, 2024 | 51.12 Mn |
| Mar 31, 2024 | 38.70 Mn |
| Dec 31, 2023 | 46.16 Mn |
| Sep 30, 2023 | 40.52 Mn |
| Jun 30, 2023 | 33.16 Mn |
| Mar 31, 2023 | 32.93 Mn |
| Dec 31, 2022 | 27.62 Mn |
| Sep 30, 2022 | 28,828.00 |
| Jun 30, 2022 | 32.88 Mn |
| Mar 31, 2022 | 31.45 Mn |
| Dec 31, 2021 | 29.98 Mn |
API Access
Pharming Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();